Ealixir, Inc. Logo

Ealixir, Inc.

EAXR

(1.8)
Stock Price

1,00 USD

-4.99% ROA

109.21% ROE

-731.16x PER

Market Cap.

74.749.680,00 USD

-57.36% DER

0% Yield

-2.19% NPM

Ealixir, Inc. Stock Analysis

Ealixir, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Ealixir, Inc. Fundamental Stock Analysis
# Analysis Rating
1 ROE

ROE surpassing expectations (575.38%) highlights strong profitability and efficient use of shareholders' equity, making it an appealing investment prospect.

2 PBV

The stock's low PBV ratio (-0x) suggests it's undervalued, making it an attractive opportunity for investors.

3 DER

The stock has a minimal amount of debt (-70%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

4 Graham Number

Based on the Graham number, this company's stock price appears to be lower than its intrinsic value, signaling a potentially favorable investment choice.

5 ROA

The stock's ROA (-1723.2%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

6 Revenue Growth

Regrettably, this company's revenue has shown no signs of growth over the past three years, suggesting limited potential for returns and making it a less appealing choice.

7 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

The company's dividend growth has remained unchanged for three years, signaling a lack of positive momentum and making it a less favorable investment choice.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

The company's stock shows signs of being overvalued (-2) according to Warren Buffett's formula, indicating a potential downside as its market price exceeds its estimated intrinsic value.

Ealixir, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Ealixir, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Sell
2 MACD Sell
3 RSI Buy
4 Stoch RSI Sell

Ealixir, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Ealixir, Inc. Revenue
Year Revenue Growth
1996 0
1997 196.891 100%
1998 962.461 79.54%
1999 2.100.000 54.17%
2000 1.459.920 -43.84%
2001 5.547.963 73.69%
2002 6.107.095 9.16%
2003 2.344.251 -160.51%
2004 1.338.373 -75.16%
2005 1.806.295 25.91%
2006 2.432.922 25.76%
2007 1.621.277 -50.06%
2008 966.000 -67.83%
2009 34.337.063 97.19%
2010 34.060.505 -0.81%
2011 15.118.728 -125.29%
2011 15.786.213 4.23%
2012 10.748.866 -46.86%
2018 963.541 -1015.56%
2019 1.319.759 26.99%
2020 1.671.042 21.02%
2021 3.538.007 52.77%
2022 4.140.030 14.54%
2023 5.051.624 18.05%
2024 1.114.944 -353.08%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Ealixir, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
1996 0
1997 544.585 100%
1998 755.080 27.88%
1999 800.000 5.62%
2000 600.957 -33.12%
2001 1.228.139 51.07%
2002 1.475.063 16.74%
2003 719.965 -104.88%
2004 648.179 -11.08%
2005 525.930 -23.24%
2006 1.064.934 50.61%
2007 781.394 -36.29%
2008 234.000 -233.93%
2009 0 0%
2010 0 0%
2011 377.384 100%
2011 300.560 -25.56%
2012 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Ealixir, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
1996 0
1997 3.907.438 100%
1998 2.406.434 -62.37%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 6.954.057 100%
2010 5.199.888 -33.73%
2011 2.457.788 -111.57%
2011 0 0%
2012 0 0%
2018 0 0%
2019 0 0%
2020 1.447.581 100%
2021 2.843.996 49.1%
2022 2.938.708 3.22%
2023 4.699.986 37.47%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Ealixir, Inc. EBITDA
Year EBITDA Growth
1996 -22.624
1997 -5.030.019 99.55%
1998 -4.292.602 -17.18%
1999 -5.900.000 27.24%
2000 -5.893.080 -0.12%
2001 -10.754.539 45.2%
2002 -7.015.033 -53.31%
2003 -3.746.659 -87.23%
2004 -2.124.121 -76.39%
2005 -785.670 -170.36%
2006 -1.639.067 52.07%
2007 -1.528.507 -7.23%
2008 -5.142.000 70.27%
2009 -8.748.278 41.22%
2010 14.616.715 159.85%
2011 -1.013.108 1542.76%
2011 -3.520.050 71.22%
2012 -1.085.620 -224.24%
2018 -241.810 -348.96%
2019 -785.070 69.2%
2020 -399.730 -96.4%
2021 -840.320 52.43%
2022 345.920 342.92%
2023 -966.302 135.8%
2024 -2.835.880 65.93%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Ealixir, Inc. Gross Profit
Year Gross Profit Growth
1996 0
1997 37.833 100%
1998 431.916 91.24%
1999 1.500.000 71.21%
2000 479.804 -212.63%
2001 1.451.878 66.95%
2002 2.411.663 39.8%
2003 1.415.008 -70.43%
2004 1.014.525 -39.47%
2005 1.443.132 29.7%
2006 1.987.874 27.4%
2007 1.319.490 -50.65%
2008 905.000 -45.8%
2009 -658.629 237.41%
2010 1.563.486 142.13%
2011 967.604 -61.58%
2011 -578.693 267.21%
2012 339.012 270.7%
2018 -14.510 2436.4%
2019 516.691 102.81%
2020 1.047.181 50.66%
2021 2.673.798 60.84%
2022 3.262.751 18.05%
2023 3.744.132 12.86%
2024 395.092 -847.66%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Ealixir, Inc. Net Profit
Year Net Profit Growth
1996 -22.624
1997 -5.309.411 99.57%
1998 -4.031.804 -31.69%
1999 -4.400.000 8.37%
2000 -4.246.949 -3.6%
2001 -11.293.381 62.39%
2002 -18.444.478 38.77%
2003 -3.432.350 -437.37%
2004 -2.251.685 -52.43%
2005 -654.053 -244.27%
2006 -1.433.663 54.38%
2007 -2.062.988 30.51%
2008 -2.121.000 2.74%
2009 -14.562.263 85.43%
2010 -28.865.778 49.55%
2011 -8.607.384 -235.36%
2011 -10.662.607 19.28%
2012 -307.015 -3372.99%
2018 -329.512 6.83%
2019 -1.333.868 75.3%
2020 -520.638 -156.2%
2021 -334.960 -55.43%
2022 139.766 339.66%
2023 -1.188.704 111.76%
2024 -2.643.524 55.03%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Ealixir, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1996 -3.232
1997 -758.487 99.57%
1998 -503.976 -50.5%
1999 -488.889 -3.09%
2000 -151.677 -222.32%
2001 -342.224 55.68%
2002 -542.485 36.92%
2003 -83.716 -548.01%
2004 -50.037 -67.31%
2005 -14.535 -244.28%
2006 -23.124 37.14%
2007 -29.898 22.66%
2008 -24.102 -24.05%
2009 -7.762 -210.51%
2010 -8.640 10.15%
2011 -214 -3936.92%
2011 -183 -16.94%
2012 -1 0%
2018 -3.581.652 100%
2019 -95 -3770060%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Ealixir, Inc. Free Cashflow
Year Free Cashflow Growth
1996 -4.607
1997 -2.771.517 99.83%
1998 -3.775.897 26.6%
1999 -4.200.000 10.1%
2000 -3.832.290 -9.6%
2001 -9.758.166 60.73%
2002 -5.166.047 -88.89%
2003 -1.871.865 -175.98%
2004 -1.384.379 -35.21%
2005 -676.618 -104.6%
2006 -1.339.146 49.47%
2007 -1.397.891 4.2%
2008 -308.000 -353.86%
2009 -5.043.154 93.89%
2010 -2.212.815 -127.91%
2011 -1.105.137 -100.23%
2011 -241.782 -357.08%
2012 -339.336 28.75%
2019 -392.117 13.46%
2020 -1.186.291 66.95%
2021 -542.010 -118.87%
2022 -177.521 -205.32%
2023 333.648 153.21%
2024 196.490 -69.8%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Ealixir, Inc. Operating Cashflow
Year Operating Cashflow Growth
1996 -4.607
1997 -2.491.162 99.82%
1998 -3.429.486 27.36%
1999 -3.900.000 12.06%
2000 -3.711.130 -5.09%
2001 -9.219.730 59.75%
2002 -5.141.459 -79.32%
2003 -1.854.916 -177.18%
2004 -1.384.379 -33.99%
2005 -676.618 -104.6%
2006 -1.339.146 49.47%
2007 -1.397.891 4.2%
2008 -308.000 -353.86%
2009 -4.689.451 93.43%
2010 -2.204.283 -112.74%
2011 -1.105.137 -99.46%
2011 -241.782 -357.08%
2012 -339.336 28.75%
2019 -392.117 13.46%
2020 -1.186.291 66.95%
2021 -171.620 -591.23%
2022 -97.521 -75.98%
2023 405.858 124.03%
2024 201.618 -101.3%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Ealixir, Inc. Capital Expenditure
Year Capital Expenditure Growth
1996 0
1997 280.355 100%
1998 346.411 19.07%
1999 300.000 -15.47%
2000 121.160 -147.61%
2001 538.436 77.5%
2002 24.588 -2089.83%
2003 16.949 -45.07%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 353.703 100%
2010 8.532 -4045.6%
2011 0 0%
2011 0 0%
2012 0 0%
2019 0 0%
2020 0 0%
2021 370.390 100%
2022 80.000 -362.99%
2023 72.210 -10.79%
2024 5.128 -1308.15%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Ealixir, Inc. Equity
Year Equity Growth
1996 -13.732
1997 272.289 105.04%
1998 4.609.393 94.09%
1999 700.000 -558.48%
2000 13.864.352 94.95%
2001 18.865.007 26.51%
2002 497.009 -3695.71%
2003 3.309.727 84.98%
2004 3.261.456 -1.48%
2005 3.098.476 -5.26%
2006 3.922.209 21%
2007 2.862.310 -37.03%
2008 1.506.000 -90.06%
2009 1.357.336 -10.95%
2010 -11.390.895 111.92%
2011 -23.484.394 51.5%
2011 -19.475.637 -20.58%
2012 -13.835.256 -40.77%
2018 -253.080 -5366.75%
2019 -1.162.888 78.24%
2020 -1.527.910 23.89%
2021 -1.158.617 -31.87%
2022 -628.086 -84.47%
2023 -335.502 -87.21%
2024 -360.239 6.87%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Ealixir, Inc. Assets
Year Assets Growth
1996 4.360
1997 2.312.468 99.81%
1998 8.115.318 71.5%
1999 4.100.000 -97.93%
2000 16.597.406 75.3%
2001 21.769.961 23.76%
2002 10.337.063 -110.6%
2003 4.648.556 -122.37%
2004 3.551.930 -30.87%
2005 3.611.425 1.65%
2006 5.019.457 28.05%
2007 3.682.689 -36.3%
2008 1.946.000 -89.24%
2009 23.286.441 91.64%
2010 1.675.122 -1290.13%
2011 4.744.280 64.69%
2011 9.250.549 48.71%
2012 203.373 -4448.56%
2018 386.258 47.35%
2019 565.657 31.72%
2020 1.230.358 54.03%
2021 1.828.381 32.71%
2022 2.045.980 10.64%
2023 2.399.892 14.75%
2024 2.047.806 -17.19%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Ealixir, Inc. Liabilities
Year Liabilities Growth
1996 18.092
1997 2.040.179 99.11%
1998 3.505.925 41.81%
1999 3.400.000 -3.12%
2000 2.733.054 -24.4%
2001 2.904.954 5.92%
2002 9.840.054 70.48%
2003 1.338.829 -634.97%
2004 290.474 -360.91%
2005 512.949 43.37%
2006 1.097.248 53.25%
2007 820.379 -33.75%
2008 440.000 -86.45%
2009 21.929.105 97.99%
2010 13.066.017 -67.83%
2011 20.302.546 35.64%
2011 28.726.186 29.32%
2012 14.038.629 -104.62%
2018 639.338 -2095.81%
2019 1.728.545 63.01%
2020 2.758.268 37.33%
2021 2.986.998 7.66%
2022 2.674.065 -11.7%
2023 2.735.394 2.24%
2024 2.408.045 -13.59%

Ealixir, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.08
Net Income per Share
-0
Price to Earning Ratio
-731.16x
Price To Sales Ratio
16.03x
POCF Ratio
126.52
PFCF Ratio
135.01
Price to Book Ratio
-207.5
EV to Sales
16.07
EV Over EBITDA
-3930.25
EV to Operating CashFlow
126.86
EV to FreeCashFlow
135.37
Earnings Yield
-0
FreeCashFlow Yield
0.01
Market Cap
0,07 Bil.
Enterprise Value
0,07 Bil.
Graham Number
0.02
Graham NetNet
-0.03

Income Statement Metrics

Net Income per Share
-0
Income Quality
-5.78
ROE
1.09
Return On Assets
-0.05
Return On Capital Employed
0.96
Net Income per EBT
0.14
EBT Per Ebit
2.14
Ebit per Revenue
-0.07
Effective Tax Rate
0.86

Margins

Sales, General, & Administrative to Revenue
0.06
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
-0.09
Gross Profit Margin
0.77
Operating Profit Margin
-0.07
Pretax Profit Margin
-0.16
Net Profit Margin
-0.02

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.01
Free CashFlow per Share
0.01
Capex to Operating CashFlow
0.06
Capex to Revenue
0.01
Capex to Depreciation
0.11
Return on Invested Capital
0.31
Return on Tangible Assets
-0.05
Days Sales Outstanding
57.78
Days Payables Outstanding
311.37
Days of Inventory on Hand
0
Receivables Turnover
6.32
Payables Turnover
1.17
Inventory Turnover
0
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
-0,01
Tangible Book Value per Share
-0.01
Shareholders Equity per Share
-0.01
Interest Debt per Share
0
Debt to Equity
-0.57
Debt to Assets
0.1
Net Debt to EBITDA
-10.5
Current Ratio
0.35
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-1471912
Working Capital
0,00 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Ealixir, Inc. Dividends
Year Dividends Growth

Ealixir, Inc. Profile

About Ealixir, Inc.

EALIXIR Inc. operates in the digital industry in Italy and internationally. Its services include Ealixir Removal that protects the online reputation of individuals and companies, and ensures the right to be forgotten by removing negative information on the web; Newsdelete to solve problems related to financial reputation; WEBiD, which drafts detailed reports on online contents and conversations regarding individuals, brands, or companies; and Ealixir Story that assists client in writing customized information for uploading onto the Web. The company was founded in 2018 and is based in Miami, Florida.

CEO
Mr. Suneel Anant Sawant
Employee
19
Address
1200 Brickell Avenue
Miami, 33131

Ealixir, Inc. Executives & BODs

Ealixir, Inc. Executives & BODs
# Name Age
1 Mr. Enea Angelo Trevisan
Chairman & President
70
2 Mr. Mark Corrao
Chief Financial Officer
70
3 Hugo Winkler
Secretary
70
4 Mr. Suneel Anant Sawant
Chief Executive Officer & Director
70
5 Mr. Alberto Grua
Chief Operating Officer
70
6 Mr. Francesco Mazza
Chief Strategy Officer & Director
70
7 Mr. Samuele Conti
Commercial Head of Europe, Middle East & Asia Regions
70

Ealixir, Inc. Competitors